Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bb-1705 (1 trial)
bb-1701 (1 trial)
Neoplasms (Phase 1)
Trials (2 total)
Trial APIs (2 total)